GlaxoSmithKline Loses Bid to End Zofran Lawsuits
GlaxoSmithKline lost its bid to end multiple lawsuits against the company alleging that its anti-nausea drug Zofran (ondansetron) caused birth defects.
Source: Drug Industry Daily
GlaxoSmithKline lost its bid to end multiple lawsuits against the company alleging that its anti-nausea drug Zofran (ondansetron) caused birth defects.
Source: Drug Industry Daily